Dr. Eli Shalom
CEO & Co- Founder
an experienced radiopharmacist. Prior to founding Isotopia he was involved for eight years in the research and development and production of SPECT and PET isotopes in the National Nuclear Research Center at Nahal Soreq. With a Ph.D degree from the Hebrew University (Jerusalem) in the Synthesis of Novel Amine [18F] Fluorocyanoboranes & Amine [18F] Fluorocarboxyborane Esters, Dr. Shalom is regarded as one of the leading professionals in this sector in Israel. He is well known as a knowledgeable researcher with practical applications in product development of radio-isotopes including SPECT & PET tracers. Dr. Shalom has a registered patent in this field as well as many publications in the professional literature.
Director of Business Development
joined isotopia from the Foundation in 2007 as the company’s customer service and support. keren has taken on very quickly the sales and marketing division and managed the department for the last six years, during which she launched the unique diagnostic product Ga-68 PSMA and approve it for reimbursement by MOH.
Currently manages the business development department and a student at Tel Aviv University studying Health System Director. The first product launched under the Business Development Lu177-PSMA as a unique and innovative therapy for the treatment of prostate cancer.
Keren’s focus is to identify trends and opportunities in nuclear medicine, to bring new technologies and promote collaboration with global manufacturers.
Eyal Gimshi, M.Sc
Head of theray unit
Eyal Gimshi joined Isotopia from the company onset, initially as an accelerator operator on a part-time basis, while studying towards his bachelor degree in Nuclear Engineering. Subsequently Eyal became a full-timer and completed his master’s degree in Nuclear Engineering from Ben Gurion University, his thesis on a research project using the cyclotron in Isotopia. In his role as Chief Operating Officer Eyal has successfully steered the corporate operation to a highly efficient and advanced radiopharmaceutical producer.
Eyal holds a MBA in technology management, is happily married and a father of 2 beautiful daughters.
Industrial pharmacist with 35 years of experience in the pharmaceutical, radio pharmaceutical and chemical industries.
Major fields of experience:
Development and scale up of production processes.
Automatization of production processes for radio-tracers and radionuclides.
Trouble shooting of production processes.
Conceptual design of pharmaceutical production facilities.
Conceptual design of process equipment.
Establishment of QA systems in accordance with ICH-Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (API).
Preparation of Drug Master file for API’s.
Head of Sterile plant
As the Company’s Chief Financial Officer Matan heads the Accounting & Finance related endeavors.
Matan brings rich experience that includes all aspects of accounting, budgeting, fundraising, capital allocation, M&A transactions, reporting, business planning and strategy and cash flow management.
Prior to joining Isotopia, Matan served first as the financial controller and later as the CFO of Hutchison Kinrot Incubator and its portfolio companies.
He previously worked as an Assistant Financial Controller at TowerJazz Semiconductor, a publicly listed manufacturer (NASDAQ & TASE) of analog integrated circuits.
Also in the assurance services department of Ernst & Young, was FP&A analyst at Lumenis (a medical equipment company), and served as a consultant and economist at a consulting company which provides a full range of business development expertise.
Matan holds a B.A in Economics and Business Administration from Haifa University and graduated from the Accounting Studies program at Bar Ilan University. He is a certified CPA.
Dr. Haim Golan